Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates Medical Device Investing
NeuroPace Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Guidance Medical Device Investing
Ocumetics Accelerates Toward Group Two First-In-Human Study with Manufacturing Launch of Optimized Accommodating Lens Technology Investing
Orchestra BioMed Targeting BACKBEAT Trial Enrollment Completion By End of Q3 2026 and Data Presentation in Q2 2027 Medical Device Investing
Delcath Systems to Participate at the H.C. Wainwright 4th Annual BioConnect Investor Conference Life Science Investing
ATM Equity Purchases by Pulse Biosciences' Co-Chairmen Total Approximately $13.3 Million Medical Device Investing
Medtronic Study Reveals AI-Enabled Clinician Alerts Significantly Improve Evaluation and Valve Intervention For Patients With Heart Valve Disease Medical Device Investing
Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process Medical Device Investing
Pulse Biosciences to Present at the BofA Securities 2026 Healthcare Conference Medical Device Investing
Sensus Healthcare Reports First Quarter 2026 Financial Results and Business Highlights Life Science Investing
